UCBB Gross Margin

The Gross Margin of US-China Biomedical Technology Inc (UCBB) is 25.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

UCBB Gross Margin - Historical Value

Date	Value
2019-02-28	25.00%
2018-02-28	50.00%

UCBB Gross Margin - Peers Comparison

Ticker	Name	Value
BNYN	Banyan Corp	90.47%
CBDT.CN	Empower Clinics Inc	30.87%
IDXG	Interpace Biosciences Inc	63.77%
PMD	Psychemedics Corp	38.07%
AGHC	Aeon Global Health Corp	61.26%
FPCG	Avem Health Partners Inc	100.00%
MEDV.NE	Medivolve Inc	38.70%
NLH.V	Nova Leap Health Corp	38.38%
CCEL	Cryo-Cell International Inc	75.15%
XGN	Exagen Inc	59.51%
CCM	Concord Medical Services Holdings Ltd	-32.28%
GTMS.TO	Greenbrook TMS Inc	45.49%
PCHM	PharmChem Inc	63.72%
PDH.V	Premier Diversified Holdings Inc	73.06%
CTHZ	Cancer Treatment Holdings Inc	40.55%
FCHS	First Choice Healthcare Solutions Inc	100.00%
AIH	Aesthetic Medical International Holdings Group Ltd	53.07%
CO	Global Cord Blood Corp	85.26%
DSOL	Drug Free Solution Inc	7775.20%
GNOW	American CareSource Holdings Inc	85.27%
NVOS	Novo Integrated Sciences Inc	43.20%
OCLG	Oncologix Tech Inc	16.71%
SPIN	Bitech Technologies Corp	100.00%
BBAL	New York Health Care Inc	17.51%
IOM.V	Assure Holdings Corp	-124.52%
MBCN.TO	MindBeacon Holdings Inc	45.55%
NPTH.V	NeuPath Health Inc	19.03%
QMED	QMed Inc	47.76%